Treatments and Adherence to Treatment Protocols - European Commission
Funds international research on new antimicrobial treatments, treatment protocol adherence, and impacts of veterinary drug use on antimicrobial resistance across human, animal, and plant health sectors.
This grant is no longer accepting proposals
European Commission has archived this opportunity.
Funder: European Commission
Due Dates: February 2, 2026 | June 17, 2026
Funding Amounts: €31,000,000 total; project duration up to 3 years; typical awards vary by consortium and national rules
Summary: Funds transnational research on new antimicrobial treatments, adherence to protocols, and impacts of veterinary drug use on antimicrobial resistance (AMR) across One Health sectors.
Description
This grant, under the European Partnership One Health AntiMicrobial Resistance (EUP OHAMR), supports transnational research and innovation projects aimed at combating antimicrobial resistance (AMR) in human, animal, and plant health. The call encourages collaborative projects that focus on:
- Developing new combination treatments using existing or innovative antimicrobials.
- Creating tools and methods to improve adherence to treatment protocols.
- Assessing the impact of veterinary and agricultural antimicrobials on the risk of AMR transmission to humans and the environment.
The programme is part of the Horizon Europe framework and brings together 53 organizations from 30 countries, fostering cross-sector collaboration and maximizing the societal impact of research outcomes in the fight against AMR.
